Features

As new compounds and masking agents continue to emerge, analytical methods must evolve to enable their detection

Recent research reveals a complex interaction between the microbiome and the immune system in pancreatic cancer

How to avoid potential hazards

Recent evidence suggests procalcitonin tests may be able to identify COVID-19 patients with bacterial coinfections to guide antibiotic treatment

The least documented of advanced quality rules are those which rely on the broader sample context

ADME profoundly affects a drug’s properties and has long been a cornerstone of pharmacology and drug discovery

Researchers are using patient-derived tumor organoids to match patients with optimal treatments

It would be an unnecessary stretch of resources in the clinical setting to use NGS for needs that can be satisfied by Sanger sequencing

A solid understanding of effective quality rules is essential for anyone working with LC-MS/MS

Researchers and regulatory authorities are exploring ways to condense the usual vaccine development timeline

Promising results from the first in-human trials of genetically engineered malaria vaccines

Mosquito-borne diseases are transmitted when a mosquito ingests viruses, parasites, or bacteria from a host and injects them into another individual

A conversation with Dara Wright, executive vice president and president of the clinical diagnostics group at Bio-Rad

Planning now will make for a smoother transition when it comes time to reopen the lab

How multiparameter flow cytometry can give a rapid picture of a patient’s immune response from a single blood sample

Considerations for labs preparing to develop or run SARS-CoV-2 assays

Reduction of circulating cardiac biomarkers is often associated with improved prognosis, making them potentially useful in therapy guidance

Some labs are limiting their testing due to the shortages, while others are getting creative

A conversation with Dave Hickey, worldwide president of integrated diagnostic solutions at BD

Often referred to as an "invisible illness," endometriosis remains poorly understood